CBIZ Vote Nears: Earnings Beat Complicates the Deal Price
With five supplemental proxy filings submitted in seven days and a director locking in option gains at deal-proximate prices, the shareholder vote on Grant Thornton's $5.2 billion acquisition of CBIZ
CBIZ Vote Nears: Earnings Beat Complicates the Deal Price
NEW YORK, September 2 —
CBIZ, Inc. (CBZ) just posted its biggest earnings beat in four quarters, clearing consensus by 26.3%, even as a shareholder vote on Grant Thornton's $5.2 billion take-private appears imminent. The timing forces a pointed question: did the deal price model the business now showing up in results, or an earlier, slower version of it?
- Most recent quarterly EPS of $0.91 beat the $0.72 consensus by 26.3%, the best positive surprise in four quarters.
- The $5.2 billion deal values CBIZ above the $51.67 analyst standalone consensus; shares trade at $54.46.
- Institutional investors hold 97.6% of shares; the vote is effectively theirs to decide.
A Beat That Complicates the Math
CBIZ provides accounting, tax, and financial advisory through its Financial Services segment, alongside employee benefits consulting and insurance through Benefits and Insurance, primarily serving small and medium-sized businesses, governmental entities, and nonprofits. The recurring-fee franchise generates strong cash conversion: trailing free cash flow reached $241 million on $290 million in operating cash. Trailing twelve-month revenue of $2.77 billion is essentially flat, down 0.2%, and a 15.2% gross margin reflects thin-spread professional services economics. Three of the last four quarters beat consensus EPS estimates, the most recent by 26.3%, suggesting cost discipline is doing work the revenue line does not reflect.
The Acquirer's Baseline Problem
The transaction values CBIZ above what analysts modeled on a standalone basis: the consensus price target stands at $51.67 while shares trade at $54.46. At a forward P/E of 12.8x and trailing EPS of $2.08, the headline terms are not demanding. But a deal negotiated against one earnings baseline absorbs different risk when that baseline moves. CBIZ carries $1.89 billion in net debt for the acquirer to absorb; free cash flow of $241 million is the deleveraging engine the transaction is built on. Stress those assumptions with the DCF calculator.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| CBZ | $3.0B | 12.8x | -9.9% |
| ICFI | $1.6B | 11.5x | -7.7% |
| CRAI | $1.1B | 17.9x | -11.2% |
| ALG | $2.1B | 14.1x | -21.0% |
| CASS | $719M | 15.5x | +28.5% |
| KAI | $3.5B | 21.8x | -8.6% |
The Vote Arrives at an Inconvenient Moment
With a vote appearing imminent, institutional investors holding 97.6% of shares are the effective jury. Short interest at 5.1% of float does not signal widespread deal-break speculation, consistent with market expectation that the transaction closes. The open question is not whether the deal happens but whether the $5.2 billion price, set against an earlier earnings baseline, still adequately compensates shareholders given a business that beat estimates in three of the last four quarters. The specific filing worth watching: whether supplemental proxy disclosures address the fairness analysis in light of the most recent results. Run the free CBIZ, Inc. deep-dive →
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
With five supplemental proxy filings submitted in seven days and a director locking in option gains at deal-proximate prices, the shareholder vote on Grant Thornton's $5.2 billion acquisition of CBIZ appears imminent — yet the same reporting period that will close the books on an independent CBIZ produced the company's biggest earnings beat in four quarters, raising the question of whether the deal price captures the business that is actually showing up in results.
Sources & Filings